Eldeeb Mohamed A, Hohman Grace, Shahid Michael
Department of Chemistry, Illinois State University, Normal, Il, USA.
Chembiochem. 2025 Apr 1;26(7):e202400887. doi: 10.1002/cbic.202400887. Epub 2025 Jan 8.
Protein degradation is pivotal for all biochemical aspects of cellular function. In mammalian cells, protein degradation is mediated mainly by the ubiquitin proteasome system (UPS) and the autophagic-lysosomal system (ALS). Over the last two decades, different types of targeted protein degradation approaches have been developed including proteolysis targeting chimeras (PROTACs) and lysosome targeting chimeras (LYTACs), which employ the UPS to degrade intracellular proteins and the ALS to degrade extracellular and membrane proteins respectively. Nevertheless, Current targeted membrane protein degradation approaches face some inherent challenges including limited target protein degradation efficacy and cell type specific applicability. Herein, we highlight some recent developments of novel targeted membrane protein degradation modalities that exhibit wide-applicability and high protein degradation efficiency. These novel membrane protein degraders hold tremendous promise as new pharmacological and biochemical tools in targeting membrane and secretory proteins for lysosomal degradation.
蛋白质降解对于细胞功能的所有生化方面都至关重要。在哺乳动物细胞中,蛋白质降解主要由泛素蛋白酶体系统(UPS)和自噬溶酶体系统(ALS)介导。在过去二十年中,已经开发了不同类型的靶向蛋白质降解方法,包括蛋白酶靶向嵌合体(PROTACs)和溶酶体靶向嵌合体(LYTACs),它们分别利用UPS降解细胞内蛋白质和ALS降解细胞外和膜蛋白。然而,目前的靶向膜蛋白降解方法面临一些固有挑战,包括有限的靶蛋白降解效率和细胞类型特异性适用性。在此,我们重点介绍了一些新型靶向膜蛋白降解模式的最新进展,这些模式具有广泛的适用性和高蛋白降解效率。这些新型膜蛋白降解剂作为靶向膜蛋白和分泌蛋白进行溶酶体降解的新药理学和生化工具,具有巨大的应用前景。